Arkolith/Insider Trading/PAHC/Form 4

Bendheim Jack

President and CEO, Director, 10% OwnerPHIBRO ANIMAL HEALTH CORP (PAHC) · full profile →Form 4 · filed Mar 16, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$258K
Net Open-Market Flow
-$258K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 13, 2026Sell(S)5K$48.91$258K96K
Mar 12, 2026Conversion(C)100K—$0101K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2026Conversion(C)100K—$019.6M

Transaction Codes

S
Open-market sale
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-028472) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML